{
    "root": "35c9c97f-ec99-c2d8-e063-6294a90a633f",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Triamcinolone Acetonide",
    "value": "20250523",
    "ingredients": [
        {
            "name": "PETROLATUM",
            "code": "4T6H12BN9U"
        },
        {
            "name": "MINERAL OIL",
            "code": "T5L8T28FGP"
        },
        {
            "name": "TRIAMCINOLONE ACETONIDE",
            "code": "F446C597KA"
        }
    ],
    "indications": "topical corticosteroids indicated relief inflammatory pruritic manifestations corticosteroid-responsive dermatoses .",
    "contraindications": "apply affected area thin film follows : triamcinolone acetonide ointment usp , 0.025 % two four times daily ; triamcinolone acetonide ointment usp , 0.1 % two three times daily depending severity condition . occlusive dressings may used management psoriasis recalcitrant conditions . infection develops , occlusive dressings discontinued appropriate antimicrobial therapy instituted .",
    "warningsAndPrecautions": "triamcinolone acetonide ointment usp , 0.025 % available follows : 80 gram tubes ndc 76420-360-80 ( relabeled ndc 0168-0005-80 ) triamcinolone acetonide ointment usp , 0.1 % available follows : 15 gram tubes ndc 76420-361-15 ( relabeled ndc 0168-0006-15 ) 80 gram tubes ndc 76420-361-80 ( relabeled ndc 0168-0006-80 ) 453.6 gram ( 1lb ) jars ndc 76420-361-16 ( relabeled ndc 0168-0006-16 ) store 20 25°c ( 68 77°f ) [ usp controlled room temperature ] . relabeled : enovachem pharmaceuticals torrance , ca 90501",
    "adverseReactions": "topical corticosteroids contraindicated patients history hypersensitivity components preparation .",
    "indications_original": "Topical corticosteroids are indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses.",
    "contraindications_original": "Apply to the affected area as a thin film as follows: Triamcinolone Acetonide Ointment USP, 0.025% two to four times daily; Triamcinolone Acetonide Ointment USP, 0.1% two or three times daily depending on the severity of the condition. Occlusive dressings may be used for the management of psoriasis or recalcitrant conditions. If an infection develops, the use of occlusive dressings should be discontinued and appropriate antimicrobial therapy instituted.",
    "warningsAndPrecautions_original": "Triamcinolone Acetonide Ointment USP, 0.025% is available as follows: \n    80 gram tubes   NDC 76420-360-80 (relabeled from NDC 0168-0005-80)\n \n                  Triamcinolone Acetonide Ointment USP, 0.1% is available as follows: \n    15 gram tubes                NDC 76420-361-15 (relabeled from NDC 0168-0006-15) \n    80 gram tubes                NDC 76420-361-80 (relabeled from NDC 0168-0006-80) \n    453.6 gram (1lb) jars     NDC 76420-361-16 (relabeled from NDC 0168-0006-16)\n \n                  Store at 20 to 25°C (68 to 77°F) [see USP Controlled Room Temperature].\n                  \n                     Relabeled by:\n                  \n                  Enovachem PHARMACEUTICALS\n                  Torrance, CA 90501",
    "adverseReactions_original": "Topical corticosteroids are contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation."
}